Skip to Content

BioScrip completes offering

BioScrip completes offering

DENVER - BioScrip has completed a public offering of common stock, netting approximately $83.15 million. The company will use the proceeds to fund the cash portion of its acquisition of HS Infusion Holdings; repay a portion of outstanding borrowings from its revolving credit facility; and for general corporate purposes, according to a press release. BioScrip announced earlier this month that it would acquire the Hammonton, N.J.-based Home Solutions for $85 million—$80 million of it in cash.

Comments

To comment on this post, please log in to your account or set up an account now.